Trials / Completed
CompletedNCT01165840
Effect of Weight and/or Obesity on Dapsone Drug Concentrations
Population Pharmacokinetic Analysis of Dapsone in Normal, Overweight and Obese Volunteers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Texas Tech University Health Sciences Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will find how weight affects the dosing of a drug called dapsone. Currently, the amount of dapsone a patient receives is the same regardless of the patient's weight.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dapsone | 100 mg PO x 1 dose |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2010-07-20
- Last updated
- 2016-07-21
- Results posted
- 2016-07-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01165840. Inclusion in this directory is not an endorsement.